In this study, we investigated in vitro the ADCC elicited by PBMCs from NEO and MTS BC patients and correlated its extent with FcγRIIIA 158V>F and FcγRIIA 131H>R genotypes and response to trastuzumab. Here, FCGR3A is linked to breast cancer.